{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:27:42Z","timestamp":1791919662800,"version":"4.3.4"},"reference-count":179,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.critrevonc.2024.104378","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T15:38:20Z","timestamp":1715701100000},"page":"104378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2343-6494","authenticated-orcid":false,"given":"Joshua J.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Campbell S.D.","family":"Roxburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross D.","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2024.104378_bib1","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41416-022-01826-2","article-title":"Cancer cachexia: a nutritional or a systemic inflammatory syndrome?","volume":"127","author":"McGovern","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jcsm.12383","article-title":"GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community","volume":"10","author":"Cederholm","year":"2019","journal-title":"J. Cachex\u00a0Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41416-022-02099-5","article-title":"Lactate dehydrogenase: relationship with the diagnostic GLIM criterion for cachexia in patients with advanced cancer","volume":"128","author":"McGovern","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104378_bib5","unstructured":"Farhana, A. and S.L. Lappin, Biochemistry, Lactate Dehydrogenase, in StatPearls. 2023: Treasure Island (FL) ineligible companies. Disclosure: Sarah Lappin declares no relevant financial relationships with ineligible companies."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104378_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000223920","article-title":"Origin of cancer cells","volume":"9","author":"Warburg","year":"1956","journal-title":"Oncologia"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.semradonc.2004.04.004","article-title":"Lactate: mirror and motor of tumor malignancy","volume":"14","author":"Walenta","year":"2004","journal-title":"Semin Radiat. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104378_bib8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41571-022-00686-2","article-title":"The multiple roles of LDH in cancer","volume":"19","author":"Claps","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s43440-020-00179-y","article-title":"Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison","volume":"73","author":"Masi","year":"2021","journal-title":"Pharm. Rep."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104378_bib10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ncb3015","article-title":"The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis","volume":"16","author":"McAllister","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104378_bib11","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/bjc.2014.90","article-title":"Cancer and systemic inflammation: treat the tumour and treat the host","volume":"110","author":"Roxburgh","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ctrv.2011.09.001","article-title":"The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer","volume":"38","author":"Roxburgh","year":"2012","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104378_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tibs.2018.10.011","article-title":"Lactate: a metabolic driver in the tumour landscape","volume":"44","author":"Ippolito","year":"2019","journal-title":"Trends Biochem Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","article-title":"Lactate modulation of immune responses in inflammatory versus tumour microenvironments","volume":"21","author":"Certo","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2024.104378_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.critrevonc.2018.09.016","article-title":"The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: a systematic review","volume":"132","author":"Dolan","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16955-5","article-title":"The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta-analysis","volume":"7","author":"Dolan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2024.104378_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.critrevonc.2017.06.002","article-title":"The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta-analysis","volume":"116","author":"Dolan","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3892\/ol.2024.14269","article-title":"Inflammation\u2011based prognostic markers of metastatic pancreatic cancer using real\u2011world data in Japan: the Tokushukai REAl\u2011world Data (TREAD) project","volume":"27","author":"Shimoyama","year":"2024","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104378_bib19","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-147-8-200710160-00010-w1","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"147","author":"Vandenbroucke","year":"2007","journal-title":"Ann. Intern Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0169-5002(02)00508-1","article-title":"The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up","volume":"39","author":"Bremnes","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2024.104378_bib21","first-page":"02","article-title":"Thymic epithelial tumors: do we know all the prognostic factors?","author":"Knetki-Wroblewska","year":"2021","journal-title":"Thorac. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/JTO.0000000000000385","article-title":"Relevance of platinum-sensitivity status in relapsed\/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of Southwest Oncology Group trials","volume":"10","author":"Lara","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104378_bib23","doi-asserted-by":"crossref","first-page":"e960","DOI":"10.1634\/theoncologist.2018-0474","article-title":"How long have i got?\"-a prospective cohort study comparing validated prognostic factors for use in patients with advanced cancer.","volume":"24","author":"Simmons","year":"2019","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12885-021-09139-y","article-title":"Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: a post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study)","volume":"22","author":"Shibuki","year":"2022","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejso.2011.01.019","article-title":"Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: a retrospective analysis","volume":"37","author":"Sougioultzis","year":"2011","journal-title":"Eur. J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104378_bib26","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1159\/000321370","article-title":"A clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesothelioma","volume":"80","author":"Tanrikulu","year":"2010","journal-title":"Respiration"},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104378_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-014-0217-z","article-title":"Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches Group","volume":"31","author":"Tanriverdi","year":"2014","journal-title":"Med. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104378_bib28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archinte.160.6.861","article-title":"Clinical survival predictors in patients with advanced cancer","volume":"160","author":"Vigan\u00f3","year":"2000","journal-title":"Arch. Intern Med"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104378_bib29","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1007\/s00520-020-05849-4","article-title":"Underweight as a risk factor of mortality in patients with newly diagnosed multiple myeloma","volume":"29","author":"Tsai","year":"2021","journal-title":"Support. Care Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104378_bib30","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/JTO.0b013e318260e106","article-title":"Prognostic models to predict survival in non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin with or without bevacizumab","volume":"7","author":"Hoang","year":"2012","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104378_bib31","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/JTO.0000000000000690","article-title":"Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer","volume":"10","author":"Kim","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.12695","article-title":"Prognostic significance of cachexia score assessed by CT in male patients with small cell lung cancer","volume":"27","author":"Kim","year":"2018","journal-title":"Eur. J. Cancer Care"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib33","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.18632\/oncotarget.13988","article-title":"Increased body mass index is associated with improved overall survival in extranodal natural killer\/T-cell lymphoma, nasal type","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"47","key":"10.1016\/j.critrevonc.2024.104378_bib34","doi-asserted-by":"crossref","first-page":"78159","DOI":"10.18632\/oncotarget.11373","article-title":"Body mass index as a prognostic factor in patients with extranodal natural killer\/T-cell lymphoma, nasal type","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s12094-012-0938-4","article-title":"Advanced or metastatic gastric cancer in elderly patients: Clinicopathological, prognostic factors and treatments","volume":"15","author":"Lu","year":"2013","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104378_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djv291","article-title":"Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma","volume":"108","author":"Tang","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"20","key":"10.1016\/j.critrevonc.2024.104378_bib37","doi-asserted-by":"crossref","first-page":"29708","DOI":"10.18632\/oncotarget.8823","article-title":"Nomograms for predicting long-term survival in patients with non-metastatic nasopharyngeal carcinoma in an endemic area","volume":"7","author":"Zeng","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104378_bib38","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1111\/crj.12950","article-title":"Impact of baseline characteristics on extensive-stage SCLC patients treated with etoposide\/carboplatin: a secondary analysis of a phase III study","volume":"12","author":"Abdel-Rahman","year":"2018","journal-title":"Clin. Respir. J."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/1759-7714.14256","article-title":"Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 >\/=50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy","volume":"13","author":"Banna","year":"2022","journal-title":"Thorac. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104378_bib40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.eururo.2014.09.022","article-title":"Prognostic factors for survival in noncastrate metastatic prostate cancer: validation of the glass model and development of a novel simplified prognostic model","volume":"68","author":"Gravis","year":"2015","journal-title":"Eur. Urol."},{"issue":"13","key":"10.1016\/j.critrevonc.2024.104378_bib41","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.ejca.2015.05.025","article-title":"Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: a single-institution experience from an endemic area","volume":"51","author":"Huang","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104378_bib42","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/cncr.25762","article-title":"Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration-resistant nonmetastatic prostate cancer","volume":"117","author":"Smith","year":"2011","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib43","doi-asserted-by":"crossref","first-page":"76.e11","DOI":"10.1016\/j.urolonc.2019.10.014","article-title":"Prognostic significance of the controlling nutritional status (CONUT) score in advanced urothelial carcinoma patients","volume":"38","author":"Suzuki","year":"2020","journal-title":"Urol. Oncol.\u00a0Semin. Orig. Investig."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib44","article-title":"Prognostic significance of controlling nutritional status (CONUT)score in advanced urothelial carcinoma patients","volume":"18","author":"Suzuki","year":"2019","journal-title":"Eur. Urol.\u00a0Suppl."},{"issue":"27","key":"10.1016\/j.critrevonc.2024.104378_bib45","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004026","article-title":"A nomogram for predicting survival of nasopharyngeal carcinoma patients with metachronous metastasis","volume":"95","author":"Zeng","year":"2016","journal-title":"Medicine"},{"issue":"13","key":"10.1016\/j.critrevonc.2024.104378_bib46","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.ejca.2011.03.002","article-title":"Better survival in patients with metastasised kidney cancer after nephrectomy: a population-based study in the Netherlands","volume":"47","author":"Aben","year":"2011","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104378_bib47","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.urolonc.2015.12.008","article-title":"Body mass index and age are additional prognostic factors in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors","volume":"34","author":"Song","year":"2016","journal-title":"Urol. Oncol.: Semin. Orig. Investig."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104378_bib48","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1080\/01635581.2018.1560481","article-title":"Pretreatment controlling nutritional status score and lactate dehydrogenase as predictive markers of survival in patients with malignant peritoneal mesothelioma","volume":"70","author":"Wang","year":"2018","journal-title":"Nutr. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7150\/ijbs.28720","article-title":"Development and validation of a prognostic nomogram in AFP-negative hepatocellular carcinoma","volume":"15","author":"Wang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104378_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001117","article-title":"Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study","volume":"8","author":"Rutkowski","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib51","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.clcc.2018.09.008","article-title":"Prognostic value of baseline ALBI score among patients with colorectal liver metastases: a pooled analysis of two randomized trials","volume":"18","author":"Abdel-Rahman","year":"2019","journal-title":"Clin. Colorectal Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104378_bib52","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00277-018-3273-1","article-title":"Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma","volume":"97","author":"Kanemasa","year":"2018","journal-title":"Ann. Hematol."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104378_bib53","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s00345-018-2590-2","article-title":"Impact of nutritional status on the prognosis of patients with metastatic hormone-naive prostate cancer: a multicenter retrospective cohort study in Japan","volume":"37","author":"Okamoto","year":"2019","journal-title":"World J. Urol."},{"issue":"17","key":"10.1016\/j.critrevonc.2024.104378_bib54","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/cncr.29440","article-title":"Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer","volume":"121","author":"Shah","year":"2015","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104378_bib55","doi-asserted-by":"crossref","first-page":"e960","DOI":"10.1634\/theoncologist.2018-0474","article-title":"How long have i got?\"-a prospective cohort study comparing validated prognostic factors for use in patients with advanced cancer","volume":"24","author":"Simmons","year":"2019","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115895","article-title":"Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma","volume":"10","author":"Fukushima","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104378_bib57","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.urolonc.2018.11.002","article-title":"Prognostic significance of serum gamma-glutamyltransferase in patients with advanced urothelial carcinoma","volume":"37","author":"Takemura","year":"2019","journal-title":"Urol. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib58","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00277-013-1977-9","article-title":"Decreased body mass index is associated with poor prognosis in patients with multiple myeloma","volume":"93","author":"Jung","year":"2014","journal-title":"Ann. Hematol."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104378_bib59","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00277-015-2438-4","article-title":"Body mass index as a prognostic factor in Asian patients treated with chemoimmunotherapy for diffuse large B cell lymphoma, not otherwise specified","volume":"94","author":"Hwang","year":"2015","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib60","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.4143\/crt.2015.250","article-title":"Prognostic factors for risk stratification of patients with recurrent or metastatic pancreatic adenocarcinoma who were treated with gemcitabine-based chemotherapy","volume":"48","author":"Park","year":"2016","journal-title":"Cancer Res Treat."},{"issue":"15","key":"10.1016\/j.critrevonc.2024.104378_bib61","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/j.ejca.2013.06.026","article-title":"Body composition and survival in the early clinical trials setting","volume":"49","author":"Veasey Rodrigues","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib62","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jcsm.12115","article-title":"Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"7","author":"Go","year":"2016","journal-title":"J. Cachex\u00a0Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/bjh.15889","article-title":"Evaluation of the impact of cachexia on clinical outcomes in aggressive lymphoma","volume":"186","author":"Burkart","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104378_bib64","first-page":"1255","article-title":"Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM score","volume":"19","author":"Berghoff","year":"2017","journal-title":"Neuro Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104378_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2019.11.005","article-title":"Development of a prognostic model for survival time prediction in castration-resistant prostate cancer patients","volume":"38","author":"Stangl-Kremser","year":"2020","journal-title":"Urol. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104378_bib66","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.bjc.6603327","article-title":"Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable","volume":"95","author":"Vogl","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib67","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cllc.2021.01.002","article-title":"Systemic inflammatory markers of survival in epidermal growth factor-mutated non-small-cell lung cancer: single-institution analysis, systematic review, and meta-analysis","volume":"22","author":"Chan","year":"2021","journal-title":"Clin. Lung Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104378_bib68","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.clml.2016.06.001","article-title":"Revised international staging system applied to real world multiple myeloma patients","volume":"16","author":"Jimenez-Zepeda","year":"2016","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104378_bib69","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jgo.2021.10.002","article-title":"Immune related adverse events and treatment discontinuation in patients older and younger than 75 years with advanced melanoma receiving nivolumab or pembrolizumab","volume":"13","author":"Ksienski","year":"2022","journal-title":"J. Geriatr. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib70","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12029-018-0108-1","article-title":"Comparison of hematologic and other prognostic markers in metastatic colorectal cancer","volume":"50","author":"Mercier","year":"2019","journal-title":"J. Gastrointest. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104378_bib71","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/CMR.0000000000000468","article-title":"Prognostic factors for first-line therapy and overall survival of metastatic uveal melanoma: the princess margaret cancer centre experience","volume":"28","author":"Nicholas","year":"2018","journal-title":"Melanoma Res"},{"issue":"21","key":"10.1016\/j.critrevonc.2024.104378_bib72","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/cncr.28890","article-title":"Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio","volume":"120","author":"Templeton","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2018.07.025","article-title":"Patient inflammatory status and CD4+\/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer","volume":"151","author":"Pinto","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib74","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.18632\/oncotarget.14395","article-title":"Selected patients can benefit more from the management of etoposide and platinum-based chemotherapy and thoracic irradiation-a retrospective analysis of 707 small cell lung cancer patients","volume":"8","author":"Cao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2024.104378_bib75","doi-asserted-by":"crossref","first-page":"7137357","DOI":"10.1155\/2022\/7137357","article-title":"Clinical significance of serum biomarkers in stage IV non-small-cell lung cancer treated with PD-1 inhibitors: LIPI score, NLR, dNLR, LMR, and PAB","volume":"2022","author":"Chen","year":"2022","journal-title":"Dis. Markers"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib76","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1186\/s12885-018-4730-x","article-title":"Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Cancer"},{"issue":"28","key":"10.1016\/j.critrevonc.2024.104378_bib77","article-title":"Long-term outcomes and prognostic markers in gallbladder cancer","volume":"97","author":"Cui","year":"2018","journal-title":"Med. (Baltim. )"},{"issue":"23","key":"10.1016\/j.critrevonc.2024.104378_bib78","doi-asserted-by":"crossref","first-page":"37200","DOI":"10.18632\/oncotarget.16553","article-title":"Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?","volume":"8","author":"Deng","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104378_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208547","article-title":"Establishment of inflammation biomarkers-based nomograms to predict prognosis of advanced colorectal cancer patients based on real world data","volume":"13","author":"Guo","year":"2018","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.critrevonc.2024.104378_bib80","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1111\/1759-7714.13581","article-title":"Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy","volume":"12","author":"He","year":"2021","journal-title":"Thorac. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104378_bib81","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/j.cllc.2015.03.005","article-title":"Advanced lung cancer inflammation index, a new prognostic score, predicts outcome in patients with small-cell lung cancer","volume":"16","author":"He","year":"2015","journal-title":"Clin. Lung Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib82","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1620\/tjem.236.297","article-title":"Systemic immune-inflammation index, based on platelet counts and neutrophil-lymphocyte ratio, is useful for predicting prognosis in small cell lung cancer","volume":"236","author":"Hong","year":"2015","journal-title":"Tohoku J. Exp. Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib83","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12894-020-00628-z","article-title":"Prognostic value of systemic inflammatory factors NLR, LMR, PLR and LDH in penile cancer","volume":"20","author":"Hu","year":"2020","journal-title":"BMC Urol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib84","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41598-020-57968-x","article-title":"Prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma","volume":"10","author":"Jiang","year":"2020","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104378_bib85","doi-asserted-by":"crossref","first-page":"8349","DOI":"10.1007\/s13277-015-3574-0","article-title":"Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy","volume":"36","author":"Li","year":"2015","journal-title":"Tumour Biol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib86","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ajh.23422","article-title":"The glasgow prognostic score (GPS) as a novel and significant predictor of extranodal natural killer\/T-cell lymphoma, nasal type","volume":"88","author":"Li","year":"2013","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064158","article-title":"Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer\/T-cell lymphoma, nasal type","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib88","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1186\/s12885-017-3893-1","article-title":"High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104378_bib89","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1080\/01635581.2022.2032764","article-title":"The prognostic value of albumin-globulin ratio and eosinophil-neutrophil ratio in patients with advanced tumors undergoing treatment with PD-1\/PD-L1 inhibitors","volume":"74","author":"Ma","year":"2022","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104378_bib90","doi-asserted-by":"crossref","DOI":"10.1177\/10732748211053150","article-title":"Prognostic value of combined lactate dehydrogenase, C-reactive protein, cancer antigen 153 and cancer antigen 125 in metastatic breast cancer","volume":"29","author":"Ma","year":"2022","journal-title":"Cancer Control"},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104378_bib91","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00262-020-02585-w","article-title":"Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors","volume":"69","author":"Peng","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"issue":"21","key":"10.1016\/j.critrevonc.2024.104378_bib92","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1111\/1759-7714.14152","article-title":"Inflammation-nutritional markers of peripheral blood could predict survival in advanced non-small-cell lung cancer patients treated with PD-1 inhibitors","volume":"12","author":"Pu","year":"2021","journal-title":"Thorac. Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104378_bib93","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12032-014-0289-9","article-title":"Prognostic value of carbohydrate tumor markers and inflammation-based markers in metastatic or recurrent gastric cancer","volume":"31","author":"Wang","year":"2014","journal-title":"Med Oncol."},{"key":"10.1016\/j.critrevonc.2024.104378_bib94","doi-asserted-by":"crossref","first-page":"9651254","DOI":"10.1155\/2018\/9651254","article-title":"Prognostic significance of pretreatment neutrophil\/lymphocyte ratio and platelet\/lymphocyte ratio in patients with diffuse large B-cell lymphoma","volume":"2018","author":"Wang","year":"2018","journal-title":"Biomed. Res Int"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib95","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s12013-014-9845-3","article-title":"Prognostic significance of pretreatment laboratory parameters in combined small-cell lung cancer","volume":"69","author":"Wang","year":"2014","journal-title":"Cell Biochem Biophys."},{"key":"10.1016\/j.critrevonc.2024.104378_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.106428","article-title":"Prognostic value of modified systemic inflammatory score in patients with newly diagnosed high-grade gliomas","volume":"201","author":"Xie","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17130-6","article-title":"Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2024.104378_bib98","doi-asserted-by":"crossref","first-page":"45194","DOI":"10.1038\/srep45194","article-title":"Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine-based chemotherapy","volume":"7","author":"Yu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2024.104378_bib99","first-page":"6743126","article-title":"Prognostic nutritional index predicts outcome of PD-L1 negative and MSS advanced cancer treated with PD-1 inhibitors","volume":"2022","author":"Zhang","year":"2022","journal-title":"Biomed. Res Int"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib100","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.amjsurg.2015.03.022","article-title":"Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer","volume":"210","author":"Zhang","year":"2015","journal-title":"Am. J. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib101","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/CJI.0000000000000415","article-title":"Association of blood biochemical indexes and antibiotic exposure with severe immune-related adverse events in patients with advanced cancers receiving PD-1 Inhibitors","volume":"45","author":"Zhao","year":"2022","journal-title":"J. Immunother."},{"issue":"18","key":"10.1016\/j.critrevonc.2024.104378_bib102","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1002\/cam4.4171","article-title":"Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non-small cell lung cancer","volume":"10","author":"Zhao","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.critrevonc.2024.104378_bib103","doi-asserted-by":"crossref","first-page":"10481","DOI":"10.1038\/srep10481","article-title":"Ratio of C-reactive protein\/albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer","volume":"5","author":"Zhou","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib104","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s13277-014-2623-4","article-title":"A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer","volume":"36","author":"Zhou","year":"2015","journal-title":"Tumour Biol."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib105","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2478\/raon-2020-0054","article-title":"Neutrophil-to-lymphocyte ratio can predict outcome in extensive-stage small cell lung cancer","volume":"54","author":"Drpa","year":"2020","journal-title":"Radio. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib106","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/03007995.2023.2167440","article-title":"Prognostic value of pretreatment immune inflammation indices in patients with immune-related tumors","volume":"39","author":"Olgun","year":"2023","journal-title":"Curr. Med Res Opin."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib107","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1186\/s12885-017-3826-z","article-title":"Characteristics and outcome in patients with non-specific symptoms and signs of cancer referred to a fast track cancer patient pathway; a retrospective cohort study","volume":"17","author":"Jorgensen","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2024.104378_bib108","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejca.2017.07.027","article-title":"Prospective validation of a prognostic score for patients in immunotherapy phase I trials: the Gustave Roussy Immune Score (GRIm-Score)","volume":"84","author":"Bigot","year":"2017","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib109","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2340\/00015555-2872","article-title":"Blood predictive biomarkers for nivolumab in advanced melanoma","volume":"98","author":"Chasseuil","year":"2018","journal-title":"Acta Derm. Venereol."},{"issue":"24","key":"10.1016\/j.critrevonc.2024.104378_bib110","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1182\/blood.2022016945","article-title":"Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis","volume":"140","author":"Di Blasi","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib111","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/sj.bjc.6600768","article-title":"Metastatic renal carcinoma comprehensive prognostic system","volume":"88","author":"Atzpodien","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104378_bib112","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020380","article-title":"The role of the neutrophil to lymphocyte ratio for survival outcomes in patients with metastatic castration-resistant prostate cancer treated with abiraterone","volume":"18","author":"Boegemann","year":"2017","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib113","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/ijc.30498","article-title":"D-dimers in malignant melanoma: association with prognosis and dynamic variation in disease progress","volume":"140","author":"Desch","year":"2017","journal-title":"Int J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib114","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00432-012-1371-3","article-title":"Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy","volume":"139","author":"Haas","year":"2013","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104378_bib115","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1007\/s00259-022-05853-2","article-title":"Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [(177)Lu]Lu-PSMA I&T during long-term follow-up","volume":"49","author":"Hartrampf","year":"2022","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"10.1016\/j.critrevonc.2024.104378_bib116","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2017.05.038","article-title":"Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1\/cytotoxic T-lymphocyte antigen-4 inhibition","volume":"82","author":"Heppt","year":"2017","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib117","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004024","article-title":"C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer","volume":"10","author":"Klumper","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104378_bib118","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00277-013-1861-7","article-title":"Patients with malignant hematological disorders treated on a palliative care unit: prognostic impact of clinical factors","volume":"93","author":"Kripp","year":"2014","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib119","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40644-020-00322-1","article-title":"Clinical and prognostic value of tumor volumetric parameters in melanoma patients undergoing (18)F-FDG-PET\/CT: a comparison with serologic markers of tumor burden and inflammation","volume":"20","author":"Reinert","year":"2020","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.critrevonc.2024.104378_bib120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.lungcan.2020.10.008","article-title":"Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study","volume":"150","author":"Bersanelli","year":"2020","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib121","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/0284186X.2016.1260772","article-title":"Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel","volume":"56","author":"Buttigliero","year":"2017","journal-title":"Acta Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib122","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40425-018-0383-1","article-title":"Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab","volume":"6","author":"Capone","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib123","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.ju.0000146713.50673.e5","article-title":"C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy","volume":"173","author":"Casamassima","year":"2005","journal-title":"J. Urol."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104378_bib124","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1007\/s12094-020-02320-y","article-title":"Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors","volume":"22","author":"Cocorocchio","year":"2020","journal-title":"Clin. Transl. Oncol."},{"issue":"32","key":"10.1016\/j.critrevonc.2024.104378_bib125","doi-asserted-by":"crossref","first-page":"33982","DOI":"10.18632\/oncotarget.5053","article-title":"Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical management","volume":"6","author":"Del Prete","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2024.104378_bib126","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejca.2019.06.008","article-title":"A validated prognostic classifier for (V600E)BRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study","volume":"118","author":"Loupakis","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib127","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hon.2757","article-title":"Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma","volume":"38","author":"Marcheselli","year":"2020","journal-title":"Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104378_bib128","first-page":"803","article-title":"Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide","volume":"73","author":"Pisano","year":"2021","journal-title":"Minerva Urol. Nephrol."},{"issue":"3-4","key":"10.1016\/j.critrevonc.2024.104378_bib129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000236022","article-title":"Do recurrent and metastatic pancreatic cancer patients have the same outcomes with gemcitabine treatment?","volume":"77","author":"Hashimoto","year":"2009","journal-title":"Oncology"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104378_bib130","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/bjc.2012.254","article-title":"Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis","volume":"107","author":"Ishioka","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jjco\/hyy154","article-title":"Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma","volume":"49","author":"Ito","year":"2019","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib132","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10147-013-0581-2","article-title":"Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice","volume":"19","author":"Kamba","year":"2014","journal-title":"Int J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104378_bib133","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.3109\/10428194.2016.1143940","article-title":"A convenient prognostic score consisting of the Glasgow prognostic score and serum lactate dehydrogenase predicts clinical outcome in patients with diffuse large B-cell lymphoma","volume":"57","author":"Kanemasa","year":"2016","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib134","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.juro.2012.10.065","article-title":"Prognostic risk stratification of patients with urothelial carcinoma of the bladder with recurrence after radical cystectomy","volume":"189","author":"Nakagawa","year":"2013","journal-title":"J. Urol."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104378_bib135","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/jjco\/hyq059","article-title":"Impact of S-1 in patients with gemcitabine-refractory pancreatic cancer in Japan","volume":"40","author":"Nakai","year":"2010","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"47","key":"10.1016\/j.critrevonc.2024.104378_bib136","doi-asserted-by":"crossref","first-page":"77404","DOI":"10.18632\/oncotarget.12677","article-title":"Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy","volume":"7","author":"Nakamura","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib137","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10120-018-0897-8","article-title":"Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer","volume":"22","author":"Namikawa","year":"2019","journal-title":"Gastric Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104378_bib138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241580","article-title":"Clinical significance of preoperative inflammatory markers in non-small cell lung cancer patients: a multicenter retrospective study","volume":"15","author":"Takada","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib139","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11523-020-00719-9","article-title":"Impact of serum gamma-glutamyltransferase on overall survival in patients with metastatic renal cell carcinoma in the era of targeted therapy","volume":"15","author":"Takemura","year":"2020","journal-title":"Target Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib140","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jjco\/hyaa264","article-title":"External validation of the albumin, C-reactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line axitinib therapy in a Japanese multi-center cohort","volume":"51","author":"Tamura","year":"2021","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib141","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jtho.2017.10.030","article-title":"Peripheral blood biomarkers associated with clinical outcome in non-small cell lung cancer patients treated with Nivolumab","volume":"13","author":"Tanizaki","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104378_bib142","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/iju.12803","article-title":"Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era","volume":"22","author":"Tatsugami","year":"2015","journal-title":"Int J. Urol."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104378_bib143","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1002\/hed.26814","article-title":"Serum lactate dehydrogenase is a predictive biomarker in patients with oropharyngeal cancer undergoing radiotherapy: retrospective study on predictive factors","volume":"43","author":"Uehara","year":"2021","journal-title":"Head. Neck"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib144","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/MPA.0000000000000050","article-title":"Comparative outcomes between initially unresectable and recurrent cases of advanced pancreatic cancer following palliative chemotherapy","volume":"43","author":"Xue","year":"2014","journal-title":"Pancreas"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104378_bib145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/pros.23969","article-title":"Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer","volume":"80","author":"Yamada","year":"2020","journal-title":"Prostate"},{"issue":"8","key":"10.1016\/j.critrevonc.2024.104378_bib146","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/jjco\/hyab064","article-title":"Prospective observational study of the efficacy of nivolumab in Japanese patients with advanced melanoma (CREATIVE study)","volume":"51","author":"Yamazaki","year":"2021","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib147","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bjc.2014.317","article-title":"The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer","volume":"111","author":"Kang","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104378_bib148","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ejca.2007.01.031","article-title":"Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study","volume":"43","author":"Suh","year":"2007","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104378_bib149","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00520-009-0639-x","article-title":"Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study","volume":"18","author":"Suh","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.critrevonc.2024.104378_bib150","doi-asserted-by":"crossref","first-page":"e1081","DOI":"10.1016\/j.wneu.2019.03.053","article-title":"Routine blood tests do not predict survival in patients with glioblastoma-multivariable analysis of 497 patients","volume":"126","author":"Maas","year":"2019","journal-title":"World Neurosurg."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib151","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/1354750X.2021.1893814","article-title":"Readily available biomarkers predict poor survival in metastatic pancreatic cancer","volume":"26","author":"Strijker","year":"2021","journal-title":"Biomarkers"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100588","article-title":"Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment","volume":"7","author":"Aamdal","year":"2022","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib153","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ijc.33768","article-title":"Ipilimumab in a real-world population: a prospective Phase IV trial with long-term follow-up","volume":"150","author":"Aamdal","year":"2022","journal-title":"Int J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095286","article-title":"Cancer and involuntary weight loss: failure to validate a prediction score","volume":"9","author":"Baicus","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/CMR.0000000000000461","article-title":"High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors","volume":"28","author":"Teterycz","year":"2018","journal-title":"Melanoma Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104378_bib156","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/jclinpath-2020-206754","article-title":"Development, internal validation and calibration of a risk score to predict survival in patients with EGFR-mutant non-small cell lung cancer","volume":"74","author":"Ng","year":"2021","journal-title":"J. Clin. Pathol."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104378_bib157","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s10147-019-01461-7","article-title":"Clinical significance of prognostic nutritional index (PNI) in malignant melanoma","volume":"24","author":"Mirili","year":"2019","journal-title":"Int J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib158","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jgo.2021.12.004","article-title":"Pre-treatment neutrophil to lymphocyte ratio as a biomarker of frailty and predictor of survival among older adults with multiple myeloma","volume":"13","author":"Giri","year":"2022","journal-title":"J. Geriatr. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104378_bib159","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.euf.2018.08.023","article-title":"The value of neutrophil to lymphocyte ratio in patients undergoing cytoreductive nephrectomy with thrombectomy","volume":"6","author":"Peyton","year":"2020","journal-title":"Eur. Urol. Focus"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib160","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clgc.2014.03.005","article-title":"Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer","volume":"12","author":"Sonpavde","year":"2014","journal-title":"Clin. Genitourin. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib161","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7150\/ijbs.24374","article-title":"Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics","volume":"14","author":"Li","year":"2018","journal-title":"Int J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104378_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2016.12.010","article-title":"Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladder","volume":"35","author":"Nakagawa","year":"2017","journal-title":"Urol. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104378_bib163","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12029-016-9879-4","article-title":"Prognostic impact of neutrophil\/lymphocyte ratio, platelet count, CRP, and albumin levels in metastatic colorectal cancer patients treated with FOLFIRI-Bevacizumab","volume":"48","author":"Artac","year":"2017","journal-title":"J. Gastrointest. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib164","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.eururo.2008.10.012","article-title":"Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma","volume":"55","author":"Saito","year":"2009","journal-title":"Eur. Urol."},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104378_bib165","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s12094-015-1289-8","article-title":"High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer","volume":"17","author":"Shao","year":"2015","journal-title":"Clin. Transl. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib166","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104378_bib167","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091304","article-title":"The relationship between imaging-based body composition analysis and the systemic inflammatory response in patients with cancer: a systematic review","volume":"11","author":"Abbass","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2024.104378_bib168","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.clnesp.2020.08.003","article-title":"Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer","volume":"40","author":"Abbass","year":"2020","journal-title":"Clin. Nutr. ESPEN"},{"key":"10.1016\/j.critrevonc.2024.104378_bib169","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clnesp.2020.07.010","article-title":"The relationship between computed tomography derived skeletal muscle index, psoas muscle index and clinical outcomes in patients with operable colorectal cancer","volume":"39","author":"Abbass","year":"2020","journal-title":"Clin. Nutr. ESPEN"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104378_bib170","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.annonc.2022.03.274","volume":"33","author":"Hacker","year":"2022","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104378_bib171","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41416-023-02200-6","article-title":"Cancer cachexia and chronic inflammation: an unbreakable bond","volume":"128","author":"Maccio","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib172","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0663","article-title":"Association of baseline inflammation with effectiveness of nutritional support among patients with disease-related malnutrition: a secondary analysis of a randomized clinical trial","volume":"3","author":"Merker","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104378_bib173","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.annonc.2021.08.1989","article-title":"Inflammation reduces the effect of nutritional therapy on clinical outcomes in cancer patients","volume":"32","author":"Bargetzi","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104378_bib174","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.clnesp.2021.04.021","article-title":"Measurement of body composition: agreement between methods of measurement by bioimpedance and computed tomography in patients with non-small cell lung cancer","volume":"44","author":"Hansen","year":"2021","journal-title":"Clin. Nutr. ESPEN"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib175","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based glasgow prognostic score: a decade of experience in patients with cancer","volume":"39","author":"McMillan","year":"2013","journal-title":"Cancer Treat. Rev."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104378_bib176","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116206","article-title":"Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study","volume":"10","author":"Proctor","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104378_bib177","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/sj.bjc.6606087","article-title":"An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study","volume":"104","author":"Proctor","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104378_bib178","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051187","article-title":"The relationship between ECOG-PS, mGPS, BMI\/WL grade and body composition and physical function in patients with advanced cancer","volume":"12","author":"Dolan","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2024.104378_bib179","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znac319","article-title":"Prognostic role of preoperative circulating systemic inflammatory response markers in primary breast cancer: meta-analysis","author":"Savioli","year":"2022","journal-title":"Br. J. Surg."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824001215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824001215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T07:06:44Z","timestamp":1718867204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842824001215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":179,"alternative-id":["S1040842824001215"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104378","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between LDH and GLIM criteria for cancer cachexia: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104378"}}